dr. herbst on combination of nivolumab and ipilimumab in patients with nsclc
Published 4 years ago • 466 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
0:46
dr. herbst on nivolumab for nsclc
-
2:35
dr. atkins on long-term survival benefit of nivolumab/ipilimumab in advanced melanoma
-
0:59
dr. ramalingam on next steps with nivolumab/ipilimumab in nsclc
-
5:31
checkmate-227: nivolumab ipilimumab in mnsclc
-
1:02
dr. hellmann on nivolumab in combination with ipilimumab for small cell lung cancer
-
6:13
checkmate-227: testing ipilimumab/nivolumab in nsclc
-
4:50
ipilimumab/nivolumab in first-line mrcc
-
1:15
dr. postow on nivolumab combined with ipilimumab in melanoma
-
1:02
dr. hodi on nivolumab in combination with ipilimumab for advanced melanoma
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
1:34
dr. sharpless on managing toxicities with nivolumab/ipilimumab in melanoma
-
1:35
dr. herbst on immuno-oncology combinations in lung cancer
-
5:39
nivolumab plus ipilimumab in advanced melanoma
-
2:01
dr. reardon on nivolumab/ipilimumab in glioblastoma
-
1:18
dr. herbst on next-generation agents in nsclc
-
2:00
nivolumab and ipilimumab in mrcc
-
2:00
dr. overman on nivolumab and ipilimumab in patients with msi-h crc
-
1:22
dr. herbst on immune resistance in lung cancer
-
1:14
dr. herbst on long term survival with pembrolizumab in nsclc